This site is intended for healthcare professionals

Chimerix acquires Oncoceutics Inc.and with it ONC 201 currently in a registrational trial to treat H3 K27M-mutant glioma.

Read time: 1 mins
Last updated:9th Jan 2021
Published:9th Jan 2021
Type: industry
Register for free exclusive healthcare eLearning resources

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest